MedTrace Logo

Management of Sleep Apnoea Syndrome (SAS) in Patients With Vasovagal Syncope (VVS)

NCT04294524 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-03-04

No results posted yet for this study

Summary

This is a multi-centre, registry-based study whose primary objective is to evaluate the effect of treatment for sleep apnoea syndrome (SAS) on the number of syncope/malaise episodes in a population suffering from both idiopathic, recurrent vasovagal syncope/malaises and SAS.

Conditions

  • Syncope, Vasovagal
  • Sleep Apnea Syndromes

Interventions

OTHER

Sleep apnea treatment

Sleep apnea treatment as decided according to routine practice. This may be Continuous positive airway pressure (CPAP) or wearing a mandibular advancement device (MAD).

Sponsors & Collaborators

  • PEAS (Pole d'Exploration des Apnees du Sommeil)

    lead OTHER

Principal Investigators

  • Vincent Puel, MD · Pôle d'exploration des apnées su sommeil (PEAS), Nouvelle Clinique Bel-Air - Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-22
Primary Completion
2022-02-22
Completion
2022-02-22

Countries

  • France
  • Monaco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04294524 on ClinicalTrials.gov